Registered entities
Immunitybio, Inc.
Reg. No. 6387895United States
IMMUNITYBIO, INC.
Reg. No. 1326110United States
Nantkwest, Inc.
Reg. No. 431979754United States
Innovation
113 patent families (61 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 12,511 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 29 |
| 2022 | 37 |
| 2023 | 39 |
| 2024 | 49 |
| 2025 | 69 |
| 2026 | 39 |
Social engagement
Social engagement: 35.2K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
3 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Private equity | 1 | 33% |
| Other / undisclosed | 1 | 33% |
Hiring activity
Hires frequently
50 roles tracked across 8 of the last 12 months
1 Apr 2026 · Financial Accounting Analyst, Clinical Trials · El Segundo
1 Apr 2026 · Temporary - Clinical Trials Manager · Culver City
14 Mar 2026 · QA Specialist, Quality Operations · Culver City
9 Mar 2026 · Clinical Trials Manager · El Segundo
9 Mar 2026 · Associate, Facilities Security & Administration · San Diego
Based on job postings tracked across public sources.
Recent activity
29 May 2026
Event
ASCO 2026
22 May 2026
Partnership
U.S. Food and Drug Administration (FDA)